Metabolic syndrome, cardiovascular risk and screening for subclinical atherosclerosis.
about
The association between Type D personality and the metabolic syndrome: a cross-sectional study in a University-based outpatient lipid clinic.The impact of estradiol and 1,25(OH)2D3 on metabolic syndrome in middle-aged Taiwanese males.The Associations of Novel Vitamin D3 Metabolic Gene CYP27A1 Polymorphism, Adiponectin/Leptin Ratio, and Metabolic Syndrome in Middle-Aged Taiwanese Males.Influence of obesity and metabolic dysfunction on the endothelial control in the coronary circulation.Influence of Malondialdehyde and Matrix Metalloproteinase-9 on Progression of Carotid Atherosclerosis in Chronic Renal Disease with Cardiometabolic SyndromeCardiac anesthesia and surgery in geriatric patients: epidemiology, current surgical outcomes, and future directions.Brachial-Ankle Pulse Wave Velocity is Associated with Composite Carotid and Coronary Atherosclerosis in a Middle-Aged Asymptomatic Population.Metabolic hypertension: concept and practice.Cardiovascular Risk Stratification in Patients with Metabolic Syndrome Without Diabetes or Cardiovascular Disease: Usefulness of Metabolic Syndrome Severity Score.The metabolic syndrome in patients on peritoneal dialysis: prevalence and influence on cardiovascular morbidity.Prevalence of coronary atherosclerosis in an Asian population: findings from coronary computed tomographic angiography.Effect of psychosocial factors on metabolic syndrome in male and female blue-collar workers.The impact of the metabolic syndrome on health-related quality of life: a cross-sectional study in Greece.Risk factors associated with metabolic syndrome and cardiovascular disease among women with polycystic ovary syndrome in Tabuk, Saudi Arabia.
P2860
Q33863249-8F953904-339D-4E06-97A7-120A5C21C655Q34653701-22CED3C0-42DE-4EFD-A838-8355B6F7EC77Q34987757-3C334721-8A55-45D1-8276-BE9543835E7DQ35613484-1E08B498-B3F8-428D-B36A-D1DE2F0C6B3DQ36204524-3FA5ADE6-6989-4996-B5B0-164FC240E829Q36358228-E3D0C096-1698-41F7-BB11-5CEA5A8CFD2BQ37387202-12FA3668-7BAA-416C-B6C5-8E77A05FB87BQ38096977-6E94E9B6-E57B-4F55-B524-18813A76A507Q40202317-1CDC148E-77EB-4658-A401-3DC26C3615B1Q42125980-CF5530AC-C480-4BF1-A57C-0206A423F9D5Q44394266-33C08BAB-8D45-4A52-9DE2-88E83DBF4C8EQ45123617-589FAC01-E994-401C-AF2A-37C2C3E77017Q48892758-E7138FFB-E4BE-494F-8C13-09467D14F9AAQ49166269-8A95596D-221D-4E35-8CFF-3FFDC30A36B5
P2860
Metabolic syndrome, cardiovascular risk and screening for subclinical atherosclerosis.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on March 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Metabolic syndrome, cardiovascular risk and screening for subclinical atherosclerosis.
@en
Metabolic syndrome, cardiovascular risk and screening for subclinical atherosclerosis.
@nl
type
label
Metabolic syndrome, cardiovascular risk and screening for subclinical atherosclerosis.
@en
Metabolic syndrome, cardiovascular risk and screening for subclinical atherosclerosis.
@nl
prefLabel
Metabolic syndrome, cardiovascular risk and screening for subclinical atherosclerosis.
@en
Metabolic syndrome, cardiovascular risk and screening for subclinical atherosclerosis.
@nl
P2860
P921
P356
P1476
Metabolic syndrome, cardiovascular risk and screening for subclinical atherosclerosis.
@en
P2093
Nathan D Wong
Shaista Malik
P2860
P304
P356
10.1586/14779072.7.3.273
P577
2009-03-01T00:00:00Z